{"pageContent": "Background: Multiparametric magnetic resonance imaging (mpMRI)/transrectal ultrasound (TRUS) fusion-guided high-intensity focused ultrasound (HIFU) is a focal treatment option for MRI-visible localized prostate cancer (PCa). High-quality evidence regarding the clinical efficacy remains limited.", "metaData": {"source": "Prostate cancer: Defining biochemical failure in patients treated with HIFU\nhttps://pubmed.ncbi.nlm.nih.gov/20383185/"}}